Navigation Links
Medimetriks Pharmaceuticals, Inc. Begins Operations
Date:5/13/2008

Bradley Pharmaceuticals Founder and Senior Management Form Company

Specializing in Dermatology and Podiatry Markets

FAIRFIELD, N.J., May 13 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. announced today that it commenced operations. The newly-formed Company, led by the founder and the key Senior Management Team of the former Bradley Pharmaceuticals (NYSE: BDY), will develop, license and commercialize innovative prescription products for the Dermatology and Podiatry marketplaces. The Company is aggressively pursuing licensing opportunities, company and product acquisitions and initiating the development of a series of brands that will fill unmet needs in the marketplace. Medimetriks' objective is to build a robust product portfolio and become a leading Dermatology and Podiatry specialty company.

Bradley Pharmaceuticals was acquired earlier this year by Nycomed for approximately $350MM. Bradley's Doak Dermatologics Division, which represented approximately 80% of Bradley's revenue, was a leading dermatology company and the largest independent pharmaceutical marketer to the podiatry specialty. Bradley Glassman, the former Senior Vice President of Sales and Marketing for Bradley, will serve as President and CEO of Medimetriks Pharmaceuticals, Brent Lenczycki as Chief Financial Officer and Alan Goldstein as Executive Vice President, Business Development. Daniel Glassman, the former President and CEO of Bradley, will serve as Medimetriks' Chairman of the Board.

"We have an experienced management team that was an important part of Bradley's success," stated Daniel Glassman. "We also have added a strong support team that will allow Medimetriks to achieve both short and long term success. Medimetriks' talent
'/>"/>

SOURCE Medimetriks Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
2. Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
3. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT
4. Jazz Pharmaceuticals, Inc. to Announce First Quarter Results on May 13, 2008
5. Aida Pharmaceuticals, Inc. Announces Update on Progress of Rh-Apo2L Testing
6. Aida Pharmaceuticals, Inc. Announces Completion of Research Institute Acquisition
7. GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in Sirtuin Research and Development
8. Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
9. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
10. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
11. Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the Peoples Republic of China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... 2015 Ralco announced today that it ... (ABN) for the exclusive worldwide rights to sell and ... is a new in-line milk system that increases the ... to move supplementation milk cups within a farrowing facility ... technology lets producers get Birthrightâ„¢ milk to the right ...
(Date:4/23/2015)... 2015 Six startups from Russia ... 4-17 as part of the U.S.-Russia Innovation Corridor ... of biotechnology startups to participate in the program ... and the University of Maryland (UMD) signed a ... respective universities in the biomedical industry in 2013. ...
(Date:4/23/2015)... , April 23, 2015  Veracyte, Inc. (NASDAQ: ... a definitive agreement to sell approximately $40 million of ... agreement, the investors will purchase an aggregate of 4,907,975 ... $8.15 per share, the closing stock price on April ... and existing investors, including Broadfin Capital, Camber Capital, Deerfield, ...
(Date:4/23/2015)... April 23, 2015  Propanc Health Group Corporation ... focuses on the development of cancer treatments for ... lead product includes PRP, a patented formulation consisting ... as well as the enzyme amylase designed to ... a combination of anti-cancer agents working in combination ...
Breaking Biology Technology:Ralco Acquires License to Birthrightâ„¢ Moveable Milk Cup 2U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 2U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 3U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 4Veracyte, Inc. Announces $40 Million Private Placement 2Veracyte, Inc. Announces $40 Million Private Placement 3Veracyte, Inc. Announces $40 Million Private Placement 4Early Stage BioTech offers Plenty of Risk; Propanc Health Group Analyst Brief Issued by BrokerBank Securities, Inc. 2
... ... working in continuous flow chemistry processing, will deal with the application of the ReactIR flow ... of over 670 publications has been recognized with several prestigious prizes and awards, including most ... ...
... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Healthcare Conference on Wednesday, November 11, at 9:30 a.m. ... may access a live webcast of the presentation on ... It is recommended that listeners log on 15 minutes ...
... 4 Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ... and webcast discussing the Company,s 2009 third quarter results on ... Flavin, Ph.D., Chairman & Chief Executive Officer, as well as ... update on the Company. A press release reporting the 2009 ...
Cached Biology Technology:Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3Advanced Life Sciences to Host 2009 Third Quarter Financial Results Conference Call and Webcast 2
(Date:4/13/2015)... , April 13, 2015  higi, a leading cloud-based ... to more fully engage with their communities around health ... privacy protected and secure API.  ... the most accessible, affordable, and convenient vehicle to receive ... The API will allow higi,s ...
(Date:4/9/2015)... 9, 2015 Synaptics Inc. (NASDAQ: SYNA ), ... that it will report financial results for the third ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
(Date:4/6/2015)... Apr. 6, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/143028 for MINIATURE, MULTI-PURPOSE ANTENNA ... NXT-ID introduces a new revolutionary method ... surrounds the use of miniature antenna modules for ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... Va. Marc Edwards and Simoni Triantafyllidou of Virginia ... Best of Children,s National Medical Center, published a 2009 ... that demonstrated a major increase in childhood lead poisoning ... The research contradicted years of government assertions that ...
... paper, paint, and biological tissue are opaque because the ... and seemingly random ways. A new experiment conducted by ... Chemistry Higher Educational Institution (ESPCI) has shown that it,s ... objects hidden behind them, provided you know enough about ...
... IN, MARCH 8, 2010 The Society for ... Dietetic Association (ADA) and American Society for Nutrition ... the American Dietetic Association, American Society for Nutrition, ... Programs for Community-Residing Older Adults," focusing on access ...
Cached Biology News:Environmental engineers receive top science paper award for investigative work 2Environmental engineers receive top science paper award for investigative work 3Nutrition services for older adults at home and in communities 2
DAPI: 4', 6-Diamino-2-phenylindole dihydrochloride. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 0.4g/mL DAPI suspended in Antifade....
Anti-Mouse Qa.m8, Ascites (Clone 5035-24.1) (mouse IgG3)...
... deuterium atoms at the 9, 10, 12, and ... an internal standard for the quantification of 13(S)-HODE ... by incubation of linoleic acid with plant and ... the adhesion of tumor cells to the endothelium ...
...
Biology Products: